Association of Mood Disorder with Cardiometabolic Multimorbidity Trajectory and Life Expectancy, a Prospective Cohort Study

Jinghua Yin,Tianqi Ma,Jinchen Li,Guogang Zhang,Xunjie Cheng,Yongping Bai

DOI: https://doi.org/10.1016/j.jad.2022.06.003

IF: 6.533

2022-01-01

Journal of Affective Disorders

Abstract:BACKGROUND:Cardiometabolic diseases (CMDs) including hypertension, coronary heart disease, diabetes and stroke, are always combined with each other, leading to cardiometabolic multimorbidity (CMM). Mood disorder was associated with onset of CMD. However, the impact of mood disorder on the transition from single CMD to CMM was poorly understood.METHODS:A total of 95,351 participants with single CMD, with median age of 59 (range 40 to 71) years from UK Biobank were enrolled at baseline. Competing risk regression models were used to estimated hazard ratios (HRs) and 95 % confidence intervals (CIs) of association between mood disorder categories and progress from single CMD to CMM. Association of mood disorder with mortality, and life expectancy differences were also calculated by flexible parametric proportion-hazard models.RESULTS:Relative associations were observed between mood disorder and the progress from first onset of CMD to CMM. Adjusted HRs for progress to CMM from those with comorbid CMD plus depression or bipolar were increased (depression: 1.23 [1.19 1.27]; bipolar: 1.47 [1.31 1.66]), compared with those with the sole CMD. Mood disorder also had impact on all-cause mortality (depression: 1.17 [1.10 1.24]; bipolar: 2.03 [1.74 2.32]) and reduced life expectancy estimates for those with single CMD.LIMITATIONS:This cohort primarily comprises White individuals. Covariates only measured at baseline and assumed unchanged during follow-up.CONCLUSIONS:Mood disorder conferred greater hazard on the CMM and mortality outcome. This study highlighted the importance of depression and bipolar in disease progression, from single CMD, to multimorbidity or mortality.